Arvaya Healthcare Reports Consolidated Profit Turnaround

₹1.47 crore consolidated net profit; ₹9.11 crore consolidated revenue for Q4 FY26.

Reader Takeaway: Consolidation drives profit turnaroud; standalone loss and litigation remain areas to watch.

What just happened

Arvaya Healthcare Limited, previously known as Bijoy Hans Limited, has announced its audited financial results for the fourth quarter of the fiscal year 2026. The company reported a consolidated net profit of ₹1.47 crore on a consolidated revenue of ₹9.11 crore. This marks a significant turnaround, primarily attributed to the successful acquisition of three new healthcare subsidiaries: Health Secure Hospitals Private Limited, Arvaya Health and Wellness Private Limited, and Tec-Pool Solutions Private Limited. The total cost for acquiring these entities was ₹60.65 crore.

Meanwhile, the company's standalone operations continued to incur losses, with a net loss of ₹0.63 crore reported on nil standalone revenue for the same quarter.

Why this matters

The shift to consolidated profitability is a key development for shareholders, indicating a successful integration of recent acquisitions and a strategic pivot towards a healthcare-focused business model. The name change to Arvaya Healthcare Limited, effective May 11, 2026, further solidifies this new direction. However, the persistent standalone losses highlight a dual-performance scenario, where the group's overall health is now heavily dependent on its subsidiaries.

The backstory

Previously operating as Bijoy Hans Ltd, the company has undergone a significant transformation. The acquisition of subsidiaries in March 2026 was a strategic move to enter and consolidate its position in the healthcare sector. This filing details the immediate financial impact of these acquisitions.

What changes now

With the new name and consolidated profitability, Arvaya Healthcare is positioning itself as a dedicated healthcare entity. Investors will be keen to see how the company manages its integrated operations and addresses the ongoing standalone losses. The successful performance of the acquired subsidiaries will be critical for future growth.

Risks to watch

A significant contingent liability of ₹3.72 crore related to litigation claims from medical consultants remains a point of attention. While management expresses confidence in a favorable outcome, the adjudication process could impact the company's financial standing.

Peer comparison

Arvaya Healthcare is entering a competitive healthcare sector. Its performance will be benchmarked against other private and public healthcare providers based on revenue growth, profitability margins, and operational efficiency of its acquired hospital and wellness assets.

Context metrics (time-bound)

• Q4 FY26 Consolidated Revenue: ₹9.11 crore (₹911.33 lakh)
• Q4 FY26 Consolidated Net Profit: ₹1.47 crore (₹146.76 lakh)
• Subsidiary Acquisition Cost: ₹60.65 crore (₹6,065.22 lakh)
• Contingent Liability: ₹3.72 crore (₹372.17 lakh)

What to track next

Investors should monitor the integration progress of the acquired subsidiaries, their individual financial contributions, and any developments regarding the ongoing litigation. Future quarterly results will indicate the sustainability of consolidated profitability and the strategy for addressing standalone operational challenges.